Portal de investigação
Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase G alpha oxidation.
Autores da FMUP
Participantes de fora da FMUP
- Kolijn, D
- Pabel, S
- Tian, YN
- Lodi, M
- Herwig, M
- Carrizzo, A
- Zhazykbayeva, S
- Kovacs, A
- Fulop, GA
- Reusch, PH
- Van Linthout, S
- Papp, Z
- van Heerebeek, L
- Vecchione, C
- Maier, LS
- Ciccarelli, M
- Tschope, C
- Mugge, A
- Bagi, Z
- Sossalla, S
- Hamdani, N
Unidades de investigação
Abstract
Filiações
Filiações não disponíveis
Proyectos asociados
Cardiac Remodelling and “Recovery” in Pregnancy as a Model to Understand the Mechanisms of CV Diseases.
Investigador Principal: Inês Maria Falcão Sousa Pires Marques
Estudo Observacional Académico (PERIMYR) . SP Cardiologia . 2019
Remodelling adversely impacts arrhythmic outcome following isolated aortic valve replacement surgery
Investigador Principal: Inês Maria Falcão Sousa Pires Marques
Estudo Clínico Académico (Remodelling) . 2020
The Heart under Pressure: Mechanisms underlying HEpEF Secondary to chronic pressure Overload or Metabolic Syndrome
Investigador Principal: Inês Maria Falcão Sousa Pires Marques
Estudo Clínico Académico . 2020
Citar a publicação
Kolijn D,Pabel S,Tian YN,Lodi M,Herwig M,Carrizzo A,Zhazykbayeva S,Kovacs A,Fulop GA,Falcao I,Reusch PH,Van S,Papp Z,van L,Vecchione C,Maier LS,Ciccarelli M,Tschope C,Mugge A,Bagi Z,Sossalla S,Hamdani N. Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase G alpha oxidation. Cardiovasc. Res. 2021. 117. (2):p. 495-507. IF:13,081. (1).
